According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...

The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

A book created to help young children understand pulmonary fibrosis has launched at the Northern Ireland Assembly ...

A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...

In this study, an up-regulation of serine/arginine-rich splicing factor 7 (SRSF7) was identified in lung fibroblasts derived from IPF patients and a bleomycin (BLM)-induced mouse model, and further ...

In interstitial lung disease (ILD), quantitative computed tomography (qCT) is effective for prognosticating and for disease monitoring.

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

Arturo Loaiza-Bonilla, MD, MSEd, systemwide chief of hematology and oncology at St. Lukes University Health Network and ...

The FDA approves a rapid test for identifying patients with NSCLC eligible for sunvozertinib, enhancing timely, precision ...

Japanese researchers have generated lung cells directly from mouse tissue. These lung cells are called Alveolar Epithelial ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.